ANO1 inhibits ferroptosis by activating the PI3K-Akt signaling pathway, and recruits cancer-associated fibroblasts by regulating the TGF-β signaling pathway, which affects CD8 + T cell-mediated anti-tumor immunity and leads to resistance to immunotherapy [103]. Here, CD8A is linked to neoplasm.